CD28 and neoplasm: Moreover, ascites-derived CD4+ T cells and CD8+ T cells exhibited significantly reduced proportions of CD28, with 63.60 ± 10.77% of CD4+ T cells and 16.05 ± 5.57% of CD8+ T cells, compared to PB and tumor samples.